Discovering Next Generation Theraies for Eye Diseases  
 



06/12/08 Acucela to Present at BIO International Convention

06/03/08 Acucela Doses First Subject in Phase I Trial for Age-Related Macular Degeneration

05/20/08 Acucela to Present at C21 Bioventures Conference

05/07/08 Acucela Files Investigational New Drug Application -- Orally-available Small Molecule for Dry Form of AMD

04/29/08 Acucela Presents Preclinical Data from Retinopathy Study Demonstrating Improvement in Retinal Abnormalities

04/22/08 Acucela Announces Presentation of Data in Preclinical Study of Retinopathy

03/18/08 Acucela to Present at INVEST NORTHWEST 2008 Conference

10/16/07 Acucela Paper Published in Experimental Eye Research

10/09/07 Award of Phase I SBIR Grant from NIH

08/21/07 Acucela Announces Screening Collaboration To Identify Novel Drugs For Macular Degeneration

06/11/07 Acucela Awarded NIH/SBIR Grant for Environmental Retinal Toxicology Program

04/05/07 Biotech Company Acucela Inc. Secures $25M in Additional Financing

01/27/07 Acucela Paper Published in Investigative Ophthalmology and Visual Science

09/06/06 Acucela to Participate at BioJapan World Business Forum

07/14/06 Acucela Paper Published in Investigative Ophthalmology and Visual Science

07/12/06 Acucela Presents at ARVO Summer Conference on Macular Degeneration

11/24/04 Acucela Inc. Secures $13.4 M in Series B Financing

11/22/04 Acucela Leading Ophthalmology Researcher to Join Acucela's Scientific Advisory Board

08/04/04 Pharmaceutical Executive to Join Acucela's Scientific Advisory Board

06/20/04 Olympus and Acucela Inc. Extend Collaboration

04/26/04 Toyama Chemical Co., Ltd., and Acucela Inc. Enter into Collaboration for Potential Ophthalmic Treatments

09/04/03 UW Signs Licensing Agreement for Study of Eye Disease

09/04/03 Asahi News: "Former Assistant Professor of the University of Washington Starts Pharmaceutical Venture Company"

07/25/03 Olympus Optical and Acucela Inc. Form Collaboration

06/25/03 Nikkei Sangyo News: "Long Term Culture of Neuronal Cells Used in Efficacy Testing for New Drugs"